PREPARATION AND EVALUATION OF NANOSUSPENSION OF POORLY SOLUBLE DRUG ALBENDAZOLE

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 1

Abstract

The aim of the present work was to enhance solubility of albendazole a class II drug by nanosuspension technology. Nanosuspensions are prepared by using wet mill, high pressure homogenizer, emulsionā€solvent diffusion, melt emulsification method and super critical fluid techniques. Nanosuspension is new carrier free colloidal drug delivery system with nano sized particles below 1000 nm, and considered as a great drug delivery technique to enhance the drug dissolution and solubility. In the present work nanosuspension is made by emulsion solvent diffusion (ESD) technique in the presence of sodium lauryl sulfate as stabilizer. All formulations showed marked improvement in dissolution and solubility compared to pure drug. Different concentrations of sodium lauryl sulphate (SLS) as stabilizers were evaluated. All formulations were in the nano size and showed marked improvement in dissolution and solubility compared to pure drug of micron size. Finally it was concluded that formulating poorly soluble drugs in the form of nanosuspension would be a promising approach in delivery of class II drugs by oral route in a simple and effective way.

Authors and Affiliations

Chaudhari Bharat*| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan 302020, India., Prof. Satyanand Tyagi| President & Founder, Tyagi Pharmacy Association (TPA) & Scientific Writer (Pharmacy), Chattarpur, New Delhi, India-110074., Patel Chirag J| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan 302020, India., Patel Pinkesh| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan 302020, India., Patel Jaimin| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan 302020, India., Umesh Kumar| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan 302020, India., Dhruv Mangukia| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan 302020, India.

Keywords

Related Articles

IKBKE GENE-A NEWLY POTENTIAL THERAPEUTIC TARGET FOR TREATING NON-SMALL CELL LUNG CANCER

The IKBKE gene is part of a family of enzyme complexes involved in increasing cellular inflammation. IKBKE over expression has been associated with breast and prostate cancers. However, it had not been linked to environm...

INTRODUCTION OF NEW ANTIMICROBIALS: CATIONIC PEPTIDES

Antimicrobial cationic peptides are of interest because they can combat multi-drug-resistant microbes. Most peptides form -helices or -sheet-like structures that can insert into and subsequently disintegrate negatively...

SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL SCREENING OF NOVEL PYRAZOLONE DERIVATIVES

Pyrazolones, versatile nitrogen containing heterocyclic compounds displaying broad spectrum of biological and pharmacological activities. The main objective of the present study was to explore newer molecules with potent...

AN OVERVIEW OF EMERGING PHARMACOLOGICAL TARGETS IN TREATMENT OF TYPE 2 DIABETES MELLITUS

Diabetes is a chronic disorder which has serious complications if not treated appropriately. A number of therapeutic agents exist for the treatment of type 2 diabetes including metformin, sulfonylureas, thiazolidinedion...

A brief cause of acute inflammation: an overview

The inflammation is a defense biologically action on living body tissue. Acute inflammation mostly causes by bacterial infection, tissue necrosis and some chemical irritant. The visual and sign of inflammation are heat (...

Download PDF file
  • EP ID EP1339
  • DOI -
  • Views 795
  • Downloads 60

How To Cite

Chaudhari Bharat*, Prof. Satyanand Tyagi, Patel Chirag J, Patel Pinkesh, Patel Jaimin, Umesh Kumar, Dhruv Mangukia (2013). PREPARATION AND EVALUATION OF NANOSUSPENSION OF POORLY SOLUBLE DRUG ALBENDAZOLE. Journal of Drug Discovery and Therapeutics, 1(1), 37-42. https://europub.co.uk/articles/-A-1339